Together, in contrast to previous results suggesting a strong tumor-promoting implication of the methyltransferase in PDAC [12,13,14], our findings in human and murine orthotopic PDAC models suggest that EZH2 depletion is not necessarily sufficient to block tumor progression in favour of a less aggressive PDAC phenotype. Here, EZH2 is linked to neoplasm.